Literature DB >> 9865636

Treatment of benign positional vertigo using heels-over-head rotation.

J M Furman1, S P Cass, B C Briggs.   

Abstract

Particle repositioning, using either bedside techniques or whole-body manipulation devices, has been used effectively to treat benign positional vertigo (BPV). We assessed the efficacy of particle repositioning using a device designed and built specifically to treat BPV that rotated patients 360 degrees heels-over-head in their sagittal body plane while their heads were turned to align the posterior semicircular canal with the plane of rotation. Eye movements were monitored during the maneuver by an infrared video recording system that allowed subsequent review of the induced nystagmus. Our results indicate that 1) heels-over-head rotation is an extremely efficacious procedure for treating patients with BPV and 2) the pattern of nystagmus during repositioning is consistent with the theory that free-floating debris is highly likely to account for BPV.

Entities:  

Mesh:

Year:  1998        PMID: 9865636     DOI: 10.1177/000348949810701209

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Benign Paroxysmal Positional Vertigo.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

2.  Successful management of benign paroxysmal positional vertigo with the epley manoeuvre.

Authors:  P Jose; V Rupa; A Job
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-12

3.  Biomechanics of horizontal canal benign paroxysmal positional vertigo.

Authors:  Suhrud M Rajguru; Marytheresa A Ifediba; Richard D Rabbitt
Journal:  J Vestib Res       Date:  2005       Impact factor: 2.435

4.  Positional down beating nystagmus in 50 patients: cerebellar disorders and possible anterior semicircular canalithiasis.

Authors:  P Bertholon; A M Bronstein; R A Davies; P Rudge; K V Thilo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.